Market Overview:
The global B-hydroxybutyrate (ketone body) assay kit market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of diabetes, alcohol or salicylate intoxication, childhood hypo-glycaemia, growth hormone deficiency, and inborn errors of metabolism. Additionally, the increasing demand for rapid and accurate diagnostic tests is also contributing to the growth of this market. However, factors such as high cost and limited availability of these kits are restraining the growth of this market. The global B-hydroxybutyrate (ketone body) assay kit market can be segmented on the basis of type into fluorometric assay and colourimetric assay. On the basis of application, it can be segmented into diabetes mellitus, alcohol or salicylate intoxication,, childhood hypo-glycaemia,,growth hormone deficiency,,inborn errors if metabolism,,and other applications. Geographically it can be divided into North America., Latin America., Europe., Asia Pacific.,and Middle East & Africa.
 Assay Kit Industry Outlook.svg)
Product Definition:
B-Hydroxybutyrate (Ketone Body) Assay Kit is a biochemical assay kit for the quantitative determination of B-hydroxybutyrate in serum, plasma and other biological fluids. The importance of B-hydroxybutyrate (ketone body) assay kit is that it helps to diagnose and monitor diabetes, obesity, ketoacidosis and other metabolic disorders.
Fluorometric Assay:
The fluorometric assay is a chemical test used for measuring the concentration of ketone bodies in urine. It is one of the most important tests used along with enzymatic and amperometry assays for monitoring ketone body metabolism in patients suffering from epilepsy, Alzheimer’s disease, and other neurological disorders.
Colourimetric Assay:
A Colourimetric assay is an analytical procedure wherein a chemical reaction takes place between a substrate and an indicator substance. The change in the color of the solution provides information regarding the progress of the reaction. This technique is widely used for measuring ketone bodies such as B-Hydroxybutyrate (Hb1Ac) in urine, serum, plasma or tissue samples.
The major advantage of this assay includes its simplicity which allows quick.
Application Insights:
The application segment includes diabetes, alcohol or salicylate intoxication, childhood hypo-glycaemia, growth hormone deficiency and inborn errors of metabolism. The global prevalence of diabetes has increased from 8.5% to 12%, thereby creating a huge demand for B-hydroxybutyrate ( ketone body) assay kits during the forecast period.
Diabetes is expected to emerge as the fastest growing application segment over the forecast period owing to an increase in type 1 and type 2 patients requiring insulin therapy coupled with rising R&D investments for developing novel drugs against Type 1 and Type 2 diabetes. Ketone bodies are considered as natural alternatives for treating both types of diabetes due to their ability to stimulate insulin secretion from pancreatic beta cells without causing any serious side effects such as hypoglycaemia or hyperglycaemia.
Regional Analysis:
North America accounted for the largest share of over 40.0% in 2017 owing to the presence of a large number of global players and increased adoption of advanced diagnostic technologies in this region. The introduction and development of new products by these companies is also expected to drive regional growth during the forecast period. For instance, Abbott launched its B-hydroxybutyrate test under NGT brand name in U.S.
Asia Pacific is anticipated to be one of the fastest growing regions due to factors such as improving healthcare infrastructure & availability, rising disposable income levels coupled with increasing awareness regarding early diagnosis & treatment methods for various metabolic disorders including diabetes.
Growth Factors:
- Increasing awareness about the benefits of ketone bodies for overall health and well-being
- Growing popularity of ketogenic diets as a means to improve overall health and lose weight
- Rising incidence of obesity and diabetes, which are both linked to increased levels of ketone bodies in the blood
- Increased research funding for studies on the role of ketone bodies in diseases such as cancer, Alzheimer's disease, and epilepsy
- Technological advances that make it easier to measure levels of B-hydroxybutyrate in blood or other body fluids
Scope Of The Report
Report Attributes
Report Details
Report Title
B-Hydroxybutyrate (Ketone Body) Assay Kit Market Research Report
By Type
Fluorometric Assay, Colourimetric Assay
By Application
Diabetes, Alcohol Or Salicylate Intoxication, Childhood Hypo-Glycaemia, Growth Hormone Deficiency, Inborn Errors of Metabolism, Other
By Companies
Merck & Co., Abcam, REAGEN LLC, LifeSpan BioSciences, Cell Biolabs, BioAssay Systems
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
156
Number of Tables & Figures
110
Customization Available
Yes, the report can be customized as per your need.
Global B-Hydroxybutyrate (Ketone Body) Assay Kit Market Report Segments:
The global B-Hydroxybutyrate (Ketone Body) Assay Kit market is segmented on the basis of:
Types
Fluorometric Assay, Colourimetric Assay
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Diabetes, Alcohol Or Salicylate Intoxication, Childhood Hypo-Glycaemia, Growth Hormone Deficiency, Inborn Errors of Metabolism, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Merck & Co.
- Abcam
- REAGEN LLC
- LifeSpan BioSciences
- Cell Biolabs
- BioAssay Systems
 Assay Kit Market Overview.svg)
Highlights of The B-Hydroxybutyrate (Ketone Body) Assay Kit Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Fluorometric Assay
- Colourimetric Assay
- By Application:
- Diabetes
- Alcohol Or Salicylate Intoxication
- Childhood Hypo-Glycaemia
- Growth Hormone Deficiency
- Inborn Errors of Metabolism
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the B-Hydroxybutyrate (Ketone Body) Assay Kit Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Assay Kit Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
The B-Hydroxybutyrate (Ketone Body) Assay Kit is a laboratory tool used to measure the level of ketones in urine.
Some of the key players operating in the b-hydroxybutyrate (ketone body) assay kit market are Merck & Co., Abcam, REAGEN LLC, LifeSpan BioSciences, Cell Biolabs, BioAssay Systems.
The b-hydroxybutyrate (ketone body) assay kit market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 B-Hydroxybutyrate (Ketone Body) Assay Kit Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 B-Hydroxybutyrate (Ketone Body) Assay Kit Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 B-Hydroxybutyrate (Ketone Body) Assay Kit Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the B-Hydroxybutyrate (Ketone Body) Assay Kit Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global B-Hydroxybutyrate (Ketone Body) Assay Kit Market Size & Forecast, 2018-2028
4.5.1 B-Hydroxybutyrate (Ketone Body) Assay Kit Market Size and Y-o-Y Growth
4.5.2 B-Hydroxybutyrate (Ketone Body) Assay Kit Market Absolute $ Opportunity
Chapter 5 Global B-Hydroxybutyrate (Ketone Body) Assay Kit Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 B-Hydroxybutyrate (Ketone Body) Assay Kit Market Size Forecast by Type
5.2.1 Fluorometric Assay
5.2.2 Colourimetric Assay
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global B-Hydroxybutyrate (Ketone Body) Assay Kit Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 B-Hydroxybutyrate (Ketone Body) Assay Kit Market Size Forecast by Applications
6.2.1 Diabetes
6.2.2 Alcohol Or Salicylate Intoxication
6.2.3 Childhood Hypo-Glycaemia
6.2.4 Growth Hormone Deficiency
6.2.5 Inborn Errors of Metabolism
6.2.6 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global B-Hydroxybutyrate (Ketone Body) Assay Kit Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 B-Hydroxybutyrate (Ketone Body) Assay Kit Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America B-Hydroxybutyrate (Ketone Body) Assay Kit Analysis and Forecast
9.1 Introduction
9.2 North America B-Hydroxybutyrate (Ketone Body) Assay Kit Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America B-Hydroxybutyrate (Ketone Body) Assay Kit Market Size Forecast by Type
9.6.1 Fluorometric Assay
9.6.2 Colourimetric Assay
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America B-Hydroxybutyrate (Ketone Body) Assay Kit Market Size Forecast by Applications
9.10.1 Diabetes
9.10.2 Alcohol Or Salicylate Intoxication
9.10.3 Childhood Hypo-Glycaemia
9.10.4 Growth Hormone Deficiency
9.10.5 Inborn Errors of Metabolism
9.10.6 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe B-Hydroxybutyrate (Ketone Body) Assay Kit Analysis and Forecast
10.1 Introduction
10.2 Europe B-Hydroxybutyrate (Ketone Body) Assay Kit Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe B-Hydroxybutyrate (Ketone Body) Assay Kit Market Size Forecast by Type
10.6.1 Fluorometric Assay
10.6.2 Colourimetric Assay
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe B-Hydroxybutyrate (Ketone Body) Assay Kit Market Size Forecast by Applications
10.10.1 Diabetes
10.10.2 Alcohol Or Salicylate Intoxication
10.10.3 Childhood Hypo-Glycaemia
10.10.4 Growth Hormone Deficiency
10.10.5 Inborn Errors of Metabolism
10.10.6 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific B-Hydroxybutyrate (Ketone Body) Assay Kit Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific B-Hydroxybutyrate (Ketone Body) Assay Kit Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific B-Hydroxybutyrate (Ketone Body) Assay Kit Market Size Forecast by Type
11.6.1 Fluorometric Assay
11.6.2 Colourimetric Assay
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific B-Hydroxybutyrate (Ketone Body) Assay Kit Market Size Forecast by Applications
11.10.1 Diabetes
11.10.2 Alcohol Or Salicylate Intoxication
11.10.3 Childhood Hypo-Glycaemia
11.10.4 Growth Hormone Deficiency
11.10.5 Inborn Errors of Metabolism
11.10.6 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America B-Hydroxybutyrate (Ketone Body) Assay Kit Analysis and Forecast
12.1 Introduction
12.2 Latin America B-Hydroxybutyrate (Ketone Body) Assay Kit Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America B-Hydroxybutyrate (Ketone Body) Assay Kit Market Size Forecast by Type
12.6.1 Fluorometric Assay
12.6.2 Colourimetric Assay
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America B-Hydroxybutyrate (Ketone Body) Assay Kit Market Size Forecast by Applications
12.10.1 Diabetes
12.10.2 Alcohol Or Salicylate Intoxication
12.10.3 Childhood Hypo-Glycaemia
12.10.4 Growth Hormone Deficiency
12.10.5 Inborn Errors of Metabolism
12.10.6 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) B-Hydroxybutyrate (Ketone Body) Assay Kit Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) B-Hydroxybutyrate (Ketone Body) Assay Kit Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) B-Hydroxybutyrate (Ketone Body) Assay Kit Market Size Forecast by Type
13.6.1 Fluorometric Assay
13.6.2 Colourimetric Assay
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) B-Hydroxybutyrate (Ketone Body) Assay Kit Market Size Forecast by Applications
13.10.1 Diabetes
13.10.2 Alcohol Or Salicylate Intoxication
13.10.3 Childhood Hypo-Glycaemia
13.10.4 Growth Hormone Deficiency
13.10.5 Inborn Errors of Metabolism
13.10.6 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 B-Hydroxybutyrate (Ketone Body) Assay Kit Market: Competitive Dashboard
14.2 Global B-Hydroxybutyrate (Ketone Body) Assay Kit Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Merck & Co.
14.3.2 Abcam
14.3.3 REAGEN LLC
14.3.4 LifeSpan BioSciences
14.3.5 Cell Biolabs
14.3.6 BioAssay Systems
